Charles River Laboratories International, Inc. ( NYSE:CRL – Get Rating ) has been given a consensus recommendation of 'Moderate Buy' by the fourteen ratings firms that are presently covering the company, MarketBeat Ratings reports. Three investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The average 12 month target price among brokers that have issued ratings on the stock in the last year is $267.75. A number of equities research analysts have issued reports on the company.

https://www.dailypolitical.com/2023/04/09/brokerages-set-charles-river-laboratories-international-inc-nysecrl-pt-at-267-75.html

#dailypolitical